Eli Lilly: The Worst May Be Already Over (Earnings Preview)

Now you can get access to the latest and highest-quality analysis of recent Wall Street buying and selling ideas with just one subscription to Beyond the Wall Investing ! There is a free trial and a special discount of 10% for you. Join us today!I initiated my coverage of Eli Lilly and Company (NYSE: LLY ) stock in late January 2025 with a "Buy" rating, arguing that the stock's multiples seemed to be justified by the business's robust growth prospects inDaniel Sereda is chief investment analyst at a family ...